Class 4 caution in use-Renacet 465 & 950 mg tablets

RenaCare NephroMed GmbH has informed the MHRA of the presence of an undeclared excipient in the coating of the tablets. This excipient is Macrogol 6000, which has always been included in Renacet Tablets but has been omitted from the list of excipients in error.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-notification-renacet-475-mg-and-950-mg-tablets-calcium-acetate-renacare-nephromed-gmbh-el-25-a15?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=23366ae3-59e2-40b3-aa14-5d94fd8c2381&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please telephone 01159 124 253 or email medinfo@stanningleypharma.co.uk

For stock control enquiries telephone 01159 124 253 or email medinfo@stanningleypharma.co.uk